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Descriptions of unique  and definitive roles for the spleen in immunologic responses 
have generally proven to be ephemeral. The vulnerability of any hypotheses claiming a 
special role for this organ relates to the fact that animals are usually able to survive 
reasonably well after splenectomy. Therefore, a unique role for the spleen analogous to 
that of the thymus or the bursa of Fabricius seems exceedingly unlikely.  However, as 
factors  responsible  for regulation  of  the immune response have been more thoroughly 
studied,  renewed possibilities  for  special  functions  of  the spleen  have emerged. 
Three major areas  of  investigation  have indicated  that  the  spleen  plays  a  unique role  in 
immunologic  responses: (a) Humoral antibody responses to intravenously inoculated 
antigens,  especially  particulate.  The classic  work of  Rowley on  rabbit  antibody  responses 
to heterologous erythrocytes defined this area (1, 2); (b) protection  against certain 
protozoal  infestations  which are more devastating  and/or  disseminated in  the absence of 
the spleen  (3);  and (c)  production  of  enhancing antibodies  and/or  factors  which promote 
the  growth or  survival  of  tissue  allografts  and  autochthonous tumors, a  role  for  the  spleen 
initially  postulated  by Prehn (4)  and studied  extensively  by Gershon and Carter (5),  and 
Ferrer (6).  The major thrust  of  these  lines  of  investigation  has been to delineate  promi- 
nent roles  for  the spleen  in  antibody  production  to  intravenously  inoculated  antigens  and 
as a site  for the removal by opsonization  and phagocytosis  of microorganisms by the 
reticuloendothelial  system. 
More recently, attention has been directed to the duality of  the immunologic 
response in which sometimes antagonistic, sometimes synergistic activities  of 
cell-mediated and antibody-mediated immune effector  mechanisms co-exist.  In 
elegant studies of  the interaction of  these two effector  modalities, Lagrange et 
al. and Mackaness et  al. (7, 8)  have shown that  the spleen can play a pivotal role 
in  determining the overall  manifestation of  immunologic responsiveness. In  this 
laboratory, evidence has recently been produced which  suggests that when 
lymphoid cells  bearing allogeneic antigens are placed into  the anterior chamber 
of  the rat eye,  an immunologically privileged site,  the speed with which alloim- 
munity as expressed by skin graft  rejection  develops depends upon the presence 
or absence of an intact spleen (9, 10). Splenectomy  before anterior chamber 
inoculation of  allogeneic cells  permits intense immunity on the part of  the host, 
reflected by shortened skin graft  survival times. Stimulated by these observa- 
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tions, experiments have been conducted to investigate whether the spleen plays 
a  role in determining  the tempo of first set allograft  rejection.  In the experi- 
ments to be described, the response of C57BL/6 female mice to isogeneic male 
skin grafts has been analyzed with regard to the effect of prior splenectomy. The 
results indicate that in this system of weak antigenic disparity, the spleen does 
play an important role in determining the speed with which grafts are rejected 
apparently  by providing  a  suppressing  influence upon the  mediators  of graft 
rejection. 
Materials  and Methods 
Animals.  C57BL/6 male and female mice used in these experiments were obtained from The 
Jackson Laboratory, Bar Harbor, Maine. All animals were adults, between 2 and 4 mo of age. 
Lymphoid Cell Suspensions.  Lymphoid cell suspensions were prepared from lymph nodes and 
spleens by the method previously described (11). Cells for inoculation intracutaneously, intraperi- 
toneally, or into the hind foot pads were adjusted to the appropriate viable cell concentration in 
Hanks' balanced salt solution. 
Skin Grafts.  Skin grafts obtained from body wall were placed orthotopically by the method of 
Billingham and  Silvers  (12).  Dressings  were  removed  at  7  days  and the  degree  of epithelial 
survival scored daily until rejected. Complete epidermal necrosis was regarded as the survival end 
point.  Median  survival  times  (MST), 1 standard  deviation  and  error  of the  mean,  and  95% 
confidence limits were derived from the method described by Litchfield (13). 
Splenectomies.  Splenectomies were  carried out through a  left lateral  flank incision under 
ether anesthesia. Sham operated controls had their spleens exteriorized through the abdominal 
wall wound, then replaced into the peritoneal cavity. 
Gamma  Irradiation.  Gamma  irradiation  of  mice  was  accomplished  in  a  Gamma-Cell  40 
cesium-137 source at a  rate of 105 rads/min. 
Popliteal Lymph Node Assays.  Popliteal lymph node assays were conducted as described by 
Ford et al. (14). Briefly, 5 x  106 donor lymphoid cells were inoculated into the hind foot pad of sex-, 
age-,  and  weight-matched  recipients.  7  days  later  the  draining  popliteal  lymph  nodes  were 
extirpated and weighed. 
Experiments  and Results 
Effect of Splenectomy  on First Set Skin Graft Rejection  Time.  In the first 
series of experiments,  C57BL/6 female mice were splenectomized or sham oper- 
ated. 30 days later, they were challenged with orthotopic grafts from syngeneic 
male donors. The results of these experiments are listed in Table I. MST of male 
skin on splenectomized females was  13 days.  By contrast,  the  MST on sham 
operated  animals  was  16.5  days.  The  difference between these two groups  is 
statistically significant.  More impressively, male grafts placed on females that 
had been splenectomized only 7 days previously displayed even shorter survival 
times,  the  MST  of these  grafts  being  reduced  to  9.0  days.  This  very brisk 
rejection reaction was comparable to that of specifically hypersensitized females 
(15) and was as rapid as if a  major H  locus incompatibility prevailed. 
Influence  of Replacement of Spleen  Cells in Splenectomized  Hosts.  In the 
following series of experiments,  evidence was sought bearing on the possibility 
that splenectomy removes a  population of cells with the capability of suppress- 
ing first  set allograft  responses.  In these  studies,  panels  of C57BL/6 females 
were splenectomized 7 days before receiving grafts of male skin. 2 days thereaf- 
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TABLE  I 
Effect of Splenectomy on First Set Skin Graft Survival 
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Experimental animals  No.  Median survival time (days ± SD)* 
Sham operated (control)  39  16.5 -  1.3 (15.1-18.0) 
Splenectomized 30 days before grafting  22  13.0 --- 1.1 (11.7-14.6) 
Splenectomized 7 days before grafting  30  9.0 +- 1.6 (7.7-10.6) 
Adult  C57BL/6  females  were  grafted  orthotopically  with  isografts  of  male  skin. 
*  Numbers in  parentheses  are  95% confidence  limits. 
TABLE  II 
Adoptive Restoration in Splenectomized C57BL/6 Females of  First Set Reactivity to Male 
Skin Grafts 
Cell  type  trans- No. of  sple-  Median survival 
Cell  transfer  donors  nectomized 
ferred  recipients  time  (days  ± S.D.)* 
Normal C57BL/6 female 
Normal C57BL/6 female 
C57BL/6  females grafted with male skin 
10 days before sacrifice 
C57BL/6 females grafted with male skin 5 
days before sacrifice 
None (control) 
Spleen  15  17.0 +_ 1.5 (13.7-21.1) 
Lymph node  4  9.0 (8-11)~ 
Spleen  13  11.5  +  1.2 (10.8-12.2) 
Spleen  16  18.0  _ 1.5 (14.6-22.2) 
30  9.0 _ 1.6 (7.7-10.6) 
* Numbers in parentheses are 95% confidence limits. 
* Range of survival times. 
ter, these animals received intraperitoneally suspensions of spleen cells  and 
lymph node cells  from normal female donors and from eusplenic female donors 
that had received male skin grafts 10 days before sacrifice.  Each host received 
one donor equivalent of lymph  nodes  or spleen  cells. The  results of these 
experiments,  which  are displayed in Table If, reveal that spleen cells from 
normal  females were able to reconstitute the first  set allograft response in 
splenectomized recipients, restoring the MST  of male skin grafts to 17.0  days. 
By contrast, suspensions of neither normal lymph node cells  nor lymph node 
cells and spleen cells  from females grafted 10 days previously with male skin 
had comparable effects  on the survival of  test  male skin grafts  in splenectomized 
females. We interpret this  to mean that there is  a resident population of  cells  in 
the spleen before  antigenic  challenge  which  is capable  of suppressing  the 
development of  the allograft  immune  response to the H-Y antigen. The results 
further suggest that these cells are not present in lymph  nodes of normal 
females and are depleted from lymph nodes and spleens of  females grafted with 
male skin 10 days beforehand. 
A subsequent experiment was carried out identical  to  the previous one except 
for the fact  that the donors of  spleen cells  were females who had received male 
skin grafts 5 days before sacrifice. The results which are also displayed in Table 
II indicate that  spleen cells at this shorter  interval  after skin allografting are 
still capable of suppressing  the development  of immunity  and the MST of male 
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TABLE  III 
Systemic GVH Reactivity of Lymphoid Cells from Splenectomized C57BL/6 Female- 
Anti-Male Animals 
Recipient  No. *  Donor 
Change in  Spleen  wts (rag)/ 
body  body wts (g) 
weight  (±2 SEM) 
% 
Normal male  (8)  F-anti-M LNC  +18  3.02 ± 0.38 
300 rad male sham splenec-  (11)  F-anti-M LNC  +19  2.59 -+ 0.16 
tomized 
Normal male (control)  (10)  None  -  3.20 ± 0.50 
300 rad male splenectomized  (15)  F-anti-M LNC  +26  - 
300 rad male  (5)  None  + 10  - 
Adult C57BL/6 males received intracutaneously  50 x 108 lymph node cells (LNC) from females 
previously splenectomized and highly sensitized to H-Y antigen. 
* Number of recipient animals. 
TABLE  IV 
Local GVH Reactivity of Lymphoid Cells from Splenectomized C57BL/6 Female-Anti- 
Male Animals 
Recipient  No. *  Donor 
Popliteal lymph node 
weight (mean -+ 2 
SEM) 
Normal male  (34)  None (control)  1.32 _ 0.16 
Normal male  (47)  Normal female  1.61 _+ 0.14 
Normal male  (38)  F-anti-M Sham Splx  2.77 ± 0.34 
Normal male  (30)  F-anti-M Splx  1.26 + 0.14 
Recipients received 5  x  108 donor cells into the hind  foot pad. Popliteal  lymph nodes were 
removed and weighed 7 days later. 
* Number of popliteal lymph nodes weighed. 
Graft-Vs.-Host Reactivity of Cells  from  Specifically Sensitized Normal  and 
Splenectomized  Females.  Because  of the  vigor  with  which  splenectomized 
females rejected first set skin allografts from male donors, we decided to evalu- 
ate  their  lymphoid  cells  for  graft-vs.-host  reactivity  (GVHR).  Accordingly, 
females that had been splenectomized or sham operated and that had rejected 
male skin grafts, were boosted 30 days later with a total of 30 ×  10  e male spleen 
cells  in  three  intracutaneous  injections.  7  days later their  lymph nodes were 
removed and  single  cell  suspensions  assayed for GVHR in two ways:  (a)  Ali- 
quote totaling 50 million cells were inoculated in five injection sites intracutane- 
ously in normal males,  and in sham operated males and splenectomized males 
exposed to 300 rad on the day of inoculation. Normal unirradiated males served 
as control.  (b)  Panels of normal C57BL/6 males were inoculated into the hind 
foot pad with 5 million lymph node cells from sham operated or splenectomized 
female donors that had rejected male skin and were boosted 7 days before. The 
results of these experiments are displayed in Tables III and IV. After intracuta- 
neous inoculations of donor cells,  none of the  male animals were observed to 
exhibit  generalized  skin  eruptions  or  other  clinical  manifestations  generally 
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gained  weight  during  the  course  of the  experiment.  Splenic  weights  from 
eusplenic  animals  failed  to  document  hypertrophy,  as  another  measure  of 
GVHR.  However, in  local assays of GVHR (Table  IV),  we were surprised  to 
discover that cells harvested from specifically sensitized females who had been 
sham  operated  evoked  significant  hypertrophy  in  draining  popliteal  lymph 
nodes while cells from splenectomized and specifically sensitized females failed 
to elicit significant popliteal node enlargement.  We conclude from these experi- 
ments that  C57BL/6 females with intact spleens respond to allografts of male 
skin by generating  within  their  lymphoid tissues  increased  numbers  of cells 
capable  of mediating  GVHR.  Alternatively,  the  lymphoid  mass  of females 
without a spleen appears to be enriched for cells capable of mediating acute skin 
graft rejection, but peculiarly devoid of GVH potential. 
Discussion 
Claims for a unique role of the spleen in immunologic responses are not new. 
It has been determined that for particulate antigens administered intravenously 
in  virgin  animals  the  spleen  is the  primary  site of antibody synthesis.  As a 
consequence of this, the spleen plays a pivotal role in protection against hema- 
togenous spread  of pathogenic  organisms  under  selected experimental  condi- 
tions.  In  addition,  the  spleen  was purported  to play a  dominant  role  in  the 
production of enhancing antibodies as described by Prehn in 1959 (4). A variety 
of experiments  carried out subsequently have merely revealed that while the 
spleen  may be an  important  source for enhancing  antibodies  with  respect to 
tumor and normal tissue allografts,  it is clearly not the only source. Enhance- 
ment can be achieved in the absence of an intact spleen (16). 
More recently, the spleen has been regarded as a site of lymphocyte differen- 
tiation  and  it  has  been  suggested  that  the  maturation  of B  lymphocytes  as 
evidenced by the  appearance  of IgD  (17)  and/or  Ia  determinants  on the  cell 
surface are events which take place in the murine  spleen  (18).  Other  reports 
have suggested that the maturation and/or production of suppressor T cells from 
a  population  of thymic-derived  precursors  occurs predominantly  if not exclu- 
sively within the spleen (19). Several recent reports have implicated the spleen 
in playing a role in regulation of immune responses. The works of Lagrange et 
al. and Mackaness et al. (7, 8) and of Kaplan and Streilein (9, 10) have suggested 
that  the  spleen  exercises  an  important  role  during  the  developing inductive 
phases of immunologic responses to certain kinds of antigens.  It is within the 
context of these ideas that the results reported herein must be considered. 
At  least  with  respect  to  the  reactivity  to  the  Y  chromosome-determined 
antigen in C57BL/6 females, the intact normal spleen would appear to play an 
important role in determining the speed with which a virgin female is capable of 
rejecting an orthotopic male skin graft.  Removal of the spleen before grafting, 
especially within  7 days, leads to a  highly significant shortening  of the MST. 
The results of our experiments further show that there is a population of cells in 
normal female spleens which is responsible for delaying the first set skin graft 
rejection reaction beyond 14 days. Specific immunization  does not appear to be 
able to  increase  this  suppressor  cell  activity;  in  fact these  cells  can  only be 
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exposure to a  male skin graft. After 10 days, the suppressing population has 
disappeared. Studies currently in progress are attempting to define the nature of 
the cell population which is responsible for this suppressing activity and to 
determine whether it is a function of living cells or cell products. Our interpreta- 
tion of the GVHR experiments conducted on cells from specifically sensitized 
and splenectomized or sham operated female donors leads us to believe that in 
the sham operated situation there appears to be an increase in numbers of cells 
capable of initiating GVH reactions. Lymphoid cell populations from animals 
that have been splenectomized and then immunized to male antigen appear to 
be devoid of cells capable of comparable reactivity. 
The concept of weak and:strong transplantation antigens is one that has been 
derived from  empiric observations  employing genetically defined strains  of 
animals and observing the speed with which grafts across diverse histocompati- 
bility barriers are rejected (20). Obviously, the speed with which an allograft of 
skin is rejected is a function not only of the strength of the histocompatibility 
antigens it bears but of  the capacity of the host to respond to these antigens. The 
source of skin used in grafting plays a minor role in determining the MST, tail 
and ear skin grafts surviving approximately 4-5 days longer on average than 
skin from flank and dorsal body wall. Our results using body wall skin agree 
well with those reported by Sena et al. (21); sham splenectomy in our hands did 
not appreciably change the MST from 16.0 days. With regard to the Y-deter- 
mined antigen, C57BL/6 females are particularly good at responding to these 
antigens thus incurring the destruction of isografts bearing them (15, 22). The 
fact that prior splenectomy shifts the balance of aggressive/suppressive forces in 
the direction of more rapid rejection suggests that even in first set skin graft 
situations, regulatory forces are brought into play which operate to suppress the 
response. One could interpret our results in splenectomized females to mean 
that weak antigens are antigens which elicit immune responses particularly 
susceptible to suppression and that this development is somehow intricately 
related to an intact normal spleen. That is, weak transplantation antigens may 
differ from strong transplantation antigens not only by virtue of differences in 
inherent immunogenicity,  but by virtue of their capacity to elicit predominantly 
suppressor activity and that this activity interferes with and delays the develop- 
ment of destructive allograft immunity. That responsiveness to weak transplan- 
tation antigens such as the H-Y is controlled by immune response genes within 
the major histocompatibility complex is consistent with the idea (21). 
Summary 
The tempo with which C57BL/6 females reject male skin isograt~s  is deter- 
mined in part by the immunogenicity of the H-Y antigen and in part by the 
capacity of the host to respond immunologically. Our studies indicate that the 
spleen plays an important role in determining the briskness of the rejection 
process in that splenectomy 7-30 days before grafting with male skin signifi- 
cantly shortens the survival time.  The results of reconstitution experiments 
suggest that  a  population of cells is  present in  spleens  of normal,  but  not 
specifically sensitized,  females which can restore the  conventional first  set 
reaction in splenectomized females. It is inferred that this resident population J.  WAYNE  STREILEIN  AND  JAMES  WIESNER  815 
normally operates in spleen-intact females to delay the development of specific 
effector responses. Lymphoid cells from H-Y antigen-sensitized,  splenectomized 
females failed to evoke graft-vs.-host responses in males whereas similar cells 
from females with spleens intact did possess graft-vs.-host potential. 
We wish to  thank Dr. R. E. Billingham for  critical  appraisal  of  the manuscript. 
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